Wells Fargo & Company Alkermes Plc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Alkermes Plc. stock. As of the latest transaction made, Wells Fargo & Company holds 72,653 shares of ALKS stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,653

Previous 69,935 3.89%

Holding current value

$2.11 Million

Previous $1.89 Million 7.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $63,084 - $74,038	2,718 Added 3.89%	72,653 $1.75 Million
Q1 2024 May 10, 2024	SELL	$26.4 - $32.56 $30,069 - $37,085	-1,139 Reduced 1.6%	69,935 $1.89 Million
Q4 2023 Feb 09, 2024	SELL	$23.37 - $28.68 $1.21 Million - $1.49 Million	-51,817 Reduced 42.17%	71,074 $1.97 Million
Q3 2023 Nov 13, 2023	SELL	$27.17 - $31.97 $434,828 - $511,647	-16,004 Reduced 11.52%	122,891 $3.44 Million
Q2 2023 Aug 15, 2023	BUY	$28.34 - $33.63 $1.13 Million - $1.34 Million	39,834 Added 40.21%	138,895 $4.35 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $1.85 Million - $2.13 Million	73,233 Added 283.54%	99,061 $2.79 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $124,377 - $148,754	-5,669 Reduced 18.0%	25,828 $674,000
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $48,752 - $70,623	-2,216 Reduced 6.57%	31,497 $704,000
Q2 2022 Aug 12, 2022	SELL	$26.4 - $30.54 $3.64 Million - $4.21 Million	-137,881 Reduced 80.35%	33,713 $1 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $771,622 - $936,181	-33,447 Reduced 16.31%	171,594 $4.51 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $2.14 Million - $3.2 Million	-99,813 Reduced 32.74%	205,041 $4.77 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $18 Million - $24.7 Million	-768,348 Reduced 71.59%	304,854 $9.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $9.98 Million - $13.4 Million	531,450 Added 98.1%	1,073,202 $26.3 Million
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $4.7 Million - $5.98 Million	257,897 Added 90.86%	541,752 $10.1 Million
Q4 2020 Feb 09, 2021	BUY	$15.39 - $22.1 $2.87 Million - $4.12 Million	186,593 Added 191.85%	283,855 $5.66 Million
Q3 2020 Nov 05, 2020	BUY	$16.16 - $20.66 $272,990 - $349,009	16,893 Added 21.02%	97,262 $1.61 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $10,954 - $15,974	-823 Reduced 1.01%	80,369 $1.56 Million
Q1 2020 May 14, 2020	BUY	$13.06 - $21.24 $1.06 Million - $1.72 Million	81,192 New	81,192 $1.17 Million

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Alkermes Plc. Transaction History